4.7 Letter

Reader Response: Effect of Levetiracetam Use Duration on Overall Survival of Isocitrate Dehydrogenase Wild-Type Glioblastoma in Adults: An Observational Study

期刊

NEUROLOGY
卷 99, 期 2, 页码 84-85

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/WNL.0000000000200900

关键词

-

向作者/读者索取更多资源

The article by Pallud et al. discusses the significant improvement in survival observed in glioma patients with isocitrate dehydrogenase wild-type who received levetiracetam throughout the standard chemoradiation protocol.
We read with interest the article by Pallud et al.(1) in which patients with isocitrate dehydrogenase wild-type glioma who took levetiracetam during the whole standard chemoradiation protocol experienced relevant improvement in survival.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据